215 related articles for article (PubMed ID: 19956958)
1. Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.
Joh EH; Lee IA; Han SJ; Chae S; Kim DH
Int J Colorectal Dis; 2010 May; 25(5):545-51. PubMed ID: 19956958
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.
Lee JH; Lee B; Lee HS; Bae EA; Lee H; Ahn YT; Lim KS; Huh CS; Kim DH
Int J Colorectal Dis; 2009 Feb; 24(2):231-7. PubMed ID: 19050899
[TBL] [Abstract][Full Text] [Related]
3. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
Hyam SR; Jang SE; Jeong JJ; Joh EH; Han MJ; Kim DH
Int Immunopharmacol; 2013 Feb; 15(2):433-41. PubMed ID: 23352442
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
[TBL] [Abstract][Full Text] [Related]
5. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
[TBL] [Abstract][Full Text] [Related]
6. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.
Lee IA; Hyun YJ; Kim DH
Eur J Pharmacol; 2010 Dec; 648(1-3):162-70. PubMed ID: 20828550
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
[TBL] [Abstract][Full Text] [Related]
8. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
[TBL] [Abstract][Full Text] [Related]
10. Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice.
Lee IA; Bae EA; Lee JH; Lee H; Ahn YT; Huh CS; Kim DH
Inflamm Res; 2010 May; 59(5):359-68. PubMed ID: 19882302
[TBL] [Abstract][Full Text] [Related]
11. Lancemaside A inhibits lipopolysaccharide-induced inflammation by targeting LPS/TLR4 complex.
Joh EH; Kim DH
J Cell Biochem; 2010 Nov; 111(4):865-71. PubMed ID: 20665542
[TBL] [Abstract][Full Text] [Related]
12. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
[TBL] [Abstract][Full Text] [Related]
13. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
14. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
Joh EH; Kim DH
Br J Pharmacol; 2011 Apr; 162(8):1731-42. PubMed ID: 21198552
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice.
Lee IA; Kim EJ; Kim DH
Planta Med; 2012 Jun; 78(9):896-8. PubMed ID: 22538477
[TBL] [Abstract][Full Text] [Related]
16. 4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization.
Jang HM; Kang GD; Van Le TK; Lim SM; Jang DS; Kim DH
Int Immunopharmacol; 2017 Apr; 45():90-97. PubMed ID: 28189973
[TBL] [Abstract][Full Text] [Related]
17. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance.
Kang GD; Kim DH
J Ethnopharmacol; 2016 Aug; 189():175-85. PubMed ID: 27224242
[TBL] [Abstract][Full Text] [Related]
18. Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-κB pathway.
Lee IA; Park YJ; Yeo HK; Han MJ; Kim DH
J Agric Food Chem; 2010 Oct; 58(20):10929-34. PubMed ID: 20923188
[TBL] [Abstract][Full Text] [Related]
19. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
[TBL] [Abstract][Full Text] [Related]
20. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages.
Lee IA; Park YJ; Joh EH; Kim DH
J Agric Food Chem; 2011 Dec; 59(24):13165-72. PubMed ID: 22060784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]